Indeed, genetic and expression studies show that eIF6 is fundamental for the progression of Non-Alcoholic Fatty Liver Disease (NAFLD) to HCC [91] and the progression of HCC itself [92,93]. Here, EIF6 is linked to metabolic dysfunction-associated steatotic liver disease.